For people with episodic migraine whose previous prophylactic treatments have failed, erenumab may represent an efficacious and tolerable treatment, according to a study recently published in the journal Cephalalgia. Placebo response rate was found to be lower among those with previous treatment failure. 6-18-19.
Subscribe To Our Weekly Newsletter
adolescents Alzheimer's disease Alzheimers anxiety back pain blood pressure botox brain caffeine children chronic migraine chronic pain cluster headache concussion concussions dementia depression diet exercise fibromyalgia Headache headache blog headaches health heart disease meditation memory migraine migraine headache migraine headaches migraines migraine triggers migraine with aura nsaids pain physical activity sleep stress stroke triggers triptans vitamin D walking women yoga